Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02142114

Assessment of Comfort Level Following an Intravitreal Injection by 30 or 32 Gauge Needles

Sponsor: California Retina Consultants

Conditions Pain

Interventions Eye injection by 30 or 32 gauge needle

Updated 7 times since 2017 Last updated: Dec 18, 2015 Started: May 31, 2014 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Pain and is currently ongoing. California Retina Consultants leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status EARLY_PHASE1
Feb 2018 — Jun 2018 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Feb 2018 [monthly]

Recruiting EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Recruiting Phase 0

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

California Retina Consultants
Genentech, Inc.
Retina Health Center

Data source: Retina Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Myers, United States